Q2 2014
Released Aug 14, 2014, after the close
10-Q filed Aug 14, 2014, 45 days after period end · 0001144204-14-050399
Q2 2014 · 10-Q
Revenue$441.00K$441.00K −23.3% vs Q2 2013−6.8% vs Q1 2014
Net Income-$5.34M-$5.34M N/M vs Q2 2013N/M vs Q1 2014
EPS Diluted-$0.21-$0.21 N/M vs Q2 2013N/M vs Q1 2014
Gross Profit$299,000−14.3%
Operating Income-$636,000N/M
Operating Cash Flowderived-$245,000N/M
Margins · derived
Gross margin67.8%+7.1 pt vs Q2 2013
Operating margin-144.2%−35.0 pt vs Q2 2013
Net margin-1210.7%−988.2 pt vs Q2 2013
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $441.00K | $575.00K | $302.00K | $637.00K |
| Net Income | -$5.34M | -$1.28M | -$754.00K | -$602.00K |
| EPS Diluted | -$0.21 | -$0.10 | -$0.07 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR